Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease

Mov Disord. 1998 May;13(3):529-32. doi: 10.1002/mds.870130324.

Abstract

Impaired debrisoquine metabolism resulting from defects in the cytochrome P450 CYP2D6-debrisoquine hydroxylase gene has been shown to be associated with the development of Parkinson's disease (PD). We studied two polymorphisms in this gene in 207 Chinese PD patients and 227 control subjects by polymerase chain reaction and restriction analysis. The G to A substitution at position 1934 in the junction of intron 3/exon 4 was detected in one sporadic PD patient and two control subjects, all of whom were heterozygous. The single base deletion at position 2637 in exon 5 was not detected in any of the study subjects. Such rarity of CYP2D6 polymorphism indicates PD in the Chinese population is associated with some other gene defects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cytochrome P-450 CYP2D6 / genetics*
  • Ethnicity / genetics*
  • Female
  • Genetic Carrier Screening
  • Hong Kong
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / enzymology
  • Parkinson Disease / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Risk

Substances

  • Cytochrome P-450 CYP2D6